JAK inhibitor selectivity: new opportunities, better drugs?

A Virtanen, FR Spinelli, JB Telliez, JJ O'Shea… - Nature Reviews …, 2024 - nature.com
Cytokines function as communication tools of the immune system, serving critical functions
in many biological responses and sha** the immune response. When cytokine production …

Non-kinase targets of protein kinase inhibitors

L Munoz - Nature Reviews Drug Discovery, 2017 - nature.com
Kinome-wide profiling platforms have comprehensively identified the relevant kinases that
are targeted by numerous protein kinase inhibitors. However, recent projects have begun to …

Identification of N-{cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide (PF-04965842): A Selective JAK1 Clinical Candidate for …

ML Vazquez, N Kaila, JW Strohbach… - Journal of medicinal …, 2018 - ACS Publications
Janus kinases (JAKs) are intracellular tyrosine kinases that mediate the signaling of
numerous cytokines and growth factors involved in the regulation of immunity, inflammation …

Dual Inhibition of TYK2 and JAK1 for the Treatment of Autoimmune Diseases: Discovery of ((S)-2,2-Difluorocyclopropyl)((1R,5S)-3-(2-((1-methyl-1H-pyrazol-4-yl) …

A Fensome, CM Ambler, E Arnold… - Journal of medicinal …, 2018 - ACS Publications
Cytokine signaling is an important characteristic of autoimmune diseases. Many pro-
inflammatory cytokines signal through the Janus kinase (JAK)/Signal transducer and …

Discovery of a JAK3-selective inhibitor: functional differentiation of JAK3-selective inhibition over pan-JAK or JAK1-selective inhibition

JB Telliez, ME Dowty, L Wang, J Jussif, T Lin… - ACS chemical …, 2016 - ACS Publications
PF-06651600, a newly discovered potent JAK3-selective inhibitor, is highly efficacious at
inhibiting γc cytokine signaling, which is dependent on both JAK1 and JAK3. PF-06651600 …

Janus kinase inhibitors for the treatment of rheumatoid arthritis demonstrate similar profiles of in vitro cytokine receptor inhibition

ME Dowty, TH Lin, MI Jesson, M Hegen… - Pharmacology …, 2019 - Wiley Online Library
Janus kinase (JAK) inhibitors have emerged as an effective class of therapies for various
inflammatory diseases such as rheumatoid arthritis (RA). JAK inhibitors function …

Design of a Janus Kinase 3 (JAK3) Specific Inhibitor 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one (PF-06651600) …

A Thorarensen, ME Dowty, ME Banker… - Journal of medicinal …, 2017 - ACS Publications
Significant work has been dedicated to the discovery of JAK kinase inhibitors resulting in
several compounds entering clinical development and two FDA approved NMEs. However …

Selective JAK3 inhibitors with a covalent reversible binding mode targeting a new induced fit binding pocket

M Forster, A Chaikuad, SM Bauer, J Holstein… - Cell chemical …, 2016 - cell.com
Janus kinases (JAKs) are a family of cytoplasmatic tyrosine kinases that are attractive targets
for the development of anti-inflammatory drugs given their roles in cytokine signaling. One …

The Identification and Pharmacological Characterization of 6-(tert-Butylsulfonyl)-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine (GSK583), a Highly Potent and …

PA Haile, BJ Votta, RW Marquis, MJ Bury… - Journal of medicinal …, 2016 - ACS Publications
RIP2 kinase is a central component of the innate immune system and enables downstream
signaling following activation of the pattern recognition receptors NOD1 and NOD2, leading …

Demonstrating in-cell target engagement using a pirin protein degradation probe (CCT367766)

NEA Chessum, SY Sharp, JJ Caldwell… - Journal of medicinal …, 2018 - ACS Publications
Demonstrating intracellular protein target engagement is an essential step in the
development and progression of new chemical probes and potential small molecule …